Scholars Central

CommentaryPublished Feb 2013

Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients

Authors: Isaac Bruce

Welcome to the Journal

Volume 3 · Issue 2 · Pages 105

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalWelcome to the Journal
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Isaac Bruce”